Stocks and Investing Stocks and Investing
Thu, November 8, 2018
Wed, November 7, 2018
Tue, November 6, 2018
Mon, November 5, 2018
Fri, November 2, 2018

Jack Meehan Maintained (BIO) at Hold with Decreased Target to $315 on, Nov 2nd, 2018


Published on 2024-10-26 10:20:19 - WOPRAI, Jack Meehan
  Print publication without navigation


Jack Meehan of Barclays, Maintained "Bio-Rad Laboratories, Inc." (BIO) at Hold with Decreased Target from $345 to $315 on, Nov 2nd, 2018.

Jack has made no other calls on BIO in the last 4 months.



There are 3 other peers that have a rating on BIO. Out of the 3 peers that are also analyzing BIO, 1 agrees with Jack's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Steve Beuchaw of "Morgan Stanley" Initiated at Hold and Held Target at $335 on, Thursday, September 20th, 2018


These are the ratings of the 2 analyists that currently disagree with Jack


  • Patrick Donnelly of "Goldman Sachs" Initiated at Strong Buy and Held Target at $350 on, Wednesday, October 17th, 2018
  • Brandon Couillard of "Jefferies" Maintained at Strong Buy with Increased Target to $355 on, Wednesday, August 8th, 2018